Skip to main content
MedPathMedPath Home
Clinical Trials/ITMCTR2000003334
ITMCTR2000003334
Not yet recruiting
Phase 4

A randomized, double-blind placebo-controlled trial for Zishen Yutai Pill for endometrial repair in patients after artificial abortion

Centre for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Centre for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Centre for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients aged 18 to 40 years;
  • •2\. The patients who were diagnosed as early intrauterine pregnancy and asked for termination of pregnancy and accepted abortion;
  • •3\. The number of previous abortion 1\-3;
  • •4\. Menstrual cycle in the first three months of pregnancy, 25\-35 days and 3\-10 days;
  • •5\. Objects who have been healthy without contraindications;
  • •6\. Patients who voluntarily cooperate with observation and treatment and have signed informed consent.

Exclusion Criteria

  • •1\. Patients who used proprietary Chinese medicine and hormone within the past month;
  • •2\. Subjects with previous allergic history to the test drug;
  • •3\. Patients with poor general conditions and intolerable to surgery;
  • •4\. Patients with previous endocrine abnormalities, uterine organic lesions and reproductive system tumors;
  • •5\. Patients with genital malformation, tumor or acute genital inflammation (such as acute pelvic inflammation, acute vaginitis, etc.);
  • •6\. The disabled patients (blind, deaf, dumb, mental disorder, mental disorder, physical disability) and the mentally ill patients specified by law;
  • •7\. Patients whose body temperature was above 37\.5 degree C twice before operation;
  • •8\. Patients who have had the previous uterine cleaning for more than 4 times;
  • •9\. Patients with severe hepatorenal insufficiency.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
A placebo-controlled, double-blind randomized trial evaluating the effect of etidronate in young patients with pseudoxanthoma elasticum on ectopic mineralization.Grönblad-Strandberg syndromePseudoxantoma elasticum100470601001498210003216
NL-OMON54216niversitair Medisch Centrum Utrecht76
Active, not recruiting
Phase 3
TEMP-PREVENT
2024-512133-33-00Universitair Medisch Centrum Utrecht76
Completed
Not Applicable
A randomized double blind, placebo-controlled trial of efficacy and safety of Kamishoyosan in patients with climacteric symptomsClimacteric symptoms
JPRN-UMIN000005079Hirosaki University Graduate School of Medicine200
Active, not recruiting
Phase 1
A double-blind, randomised placebo-controlled trial to determine whether low-dose intravenous ketamine peri-operatively can prevent chronic post-surgical pain, in patients undergoing thoracotomy or video assisted thoracic surgery (VATS). - RCT of ketamine versus placebo after thoracotomy or VATS surgery (1)Chronic post-surgical pain
EUCTR2011-000506-21-GBImperial College Healthcare NHS Trust104
Active, not recruiting
Not Applicable
Vitamin D and pharmakogenetics in glucose metabolismPolycystic Ovary SyndromeTherapeutic area: Diseases [C] - Hormonal diseases [C19]
EUCTR2011-000994-30-ATMedizinische Universität Graz